ALX Oncology Holdings Inc (NAS:ALXO) Stock News, Headlines & Updates
ALX Oncology Holdings Inc Stock News from GuruFocus
- 1
Aug 08, 2024
ALX Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Marketwired • 4:00pm
Aug 06, 2024
ALX Oncology Appoints Alan Sandler, M.D., to Board of Directors
Marketwired • 4:00pm
Jul 31, 2024
ALX Oncology Reports Topline Data From ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Improves Tumor Response in Patients With HER2-Positive Gastric Cancer
Marketwired • 4:00pm
ALX Oncology to Host Investor Call and Webcast to Share Topline Data Results From ASPEN-06 Phase 2 Clinical Trial of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer
GlobeNewswire • 5:00am
ALX Oncology to Host Investor Call and Webcast to Share Topline Data Results From ASPEN-06 Phase 2 Clinical Trial of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer
Marketwired • 5:00am
Jun 17, 2024
Insider Buying: CFO Peter Garcia Acquires Shares of ALX Oncology Holdings Inc (ALXO)
GuruFocus Research • 9:00am
Jun 02, 2024
ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1 ASPEN-07 Clinical Trial in Patients with Advanced Bladder Cancer
GlobeNewswire • 11:00am
ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1 ASPEN-07 Clinical Trial in Patients with Advanced Bladder Cancer
Marketwired • 9:00am
May 29, 2024
ALX Oncology Announces Participation in the Jefferies Global Healthcare Conference
Marketwired • 8:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news